Literature DB >> 14104553

SPIRONOLACTONE AS AN ADJUVANT TO THE TREATMENT OF CONGESTIVE CARDIAC FAILURE.

D W EVANS, C T FLEAR, J G DOMENET.   

Abstract

Entities:  

Keywords:  BLOOD; BODY WEIGHT; CHLOROTHIAZIDE; HEART FAILURE, CONGESTIVE; POTASSIUM; SODIUM; SPIRONOLACTONE; UREA; URINE

Mesh：

Substances：

Year:  1964        PMID： 14104553      PMCID： PMC2482679          DOI： 10.1136/pgmj.40.459.11

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Diuretics: a critical evaluation.

Authors:  E M HELLER
Journal:  Can Med Assoc J       Date:  1962-06-02       Impact factor: 8.262

2.  A comparison of the properties of chlorothiazide, spironolactone and a combination of both as diuretic agents.

Authors:  D A OGDEN; L SCHERR; N SPRITZ; A L RUBIN
Journal:  N Engl J Med       Date:  1961-08-24       Impact factor: 91.245

3.  The clinical application of aldosterone antagonists in the treatment of oedema.

Authors:  S SHALDON
Journal:  Proc R Soc Med       Date:  1961-04

4.  The blocking by spirolactones of the actions of aldosterone and cortisol upon the human kidney.

Authors:  J N MILLS; S THOMAS; K S WILLIAMSON
Journal:  J Endocrinol       Date:  1962-01       Impact factor: 4.286
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.